Recently the versatility of mixed and augmented reality products has come to the forefront of the news, with an Imperial led project at the Imperial College Healthcare NHS Trust. Doctors have been wearing the Microsoft Hololens headsets whilst working on the front lines of the COVID pandemic, to aid them in their care for their patients. IDTechEx have previously researched this market area in its report “Augmented, Mixed and Virtual Reality 2020-2030: Forecasts, Markets and Technologies”, which predicts th

Doctors wearing the Hololens Device. Source: Imperial.ac.uk


May 22, 2020 — Recently the versatility of mixed and augmented reality products has come to the forefront of the news, with an Imperial led project at the Imperial College Healthcare NHS Trust. Doctors have been wearing the Microsoft Hololens headsets while working on the front lines of the COVID pandemic, to aid them in their care for their patients. IDTechEx have previously researched this market area in its report “Augmented, Mixed and Virtual Reality 2020-2030: Forecasts, Markets and Technologies”, which predicts the market to be $30Bn by 2030. 

The use case for this project allows other clinicians to sit in another room, and by using Microsoft Teams, see a live video feed of the doctor who is treating the COVID-19 patients. This is utilising the remote assistance aspects which have been previously used by Hololens users for manufacturing, maintenance, and other similar applications. By using the devices, staff reduced the amount of time they must spend in a high-risk area by 83%. Not only this, they are using less PPE, as fewer clinicians are in the room during patient care.

The use of mixed and augmented reality in a hospital setting has been discussed for several years, with surgeons for example, being able to view overlays of xrays or simulating operations before the actual event. To support the rapid development of the Hololens for this use case, MedicaliSight provided an important role to ensure that the Hololens and Remote Assist has the correct security, management and network capabilities of the NHS trust. It also ensured that the device is easy for clinical adoption – the user must be able to instinctively use the device. These instinctive use cases are even more important in a high stakes environment such as caring for patients on a high-risk ward.

Mixed reality is just one part of the “Spatial reality” family, the others including augmented and virtual reality devices. In the future, more use cases such as those of the Hololens will be found, and IDTechEx predicts this market to be over $30Bn by 2030, and part of this will come from an uptake of devices used in these novel, high impact use cases.

To identify these use cases, it is important to have a holistic overview of the current capabilities, future growth opportunities, and hindrances of this technology. IDTechEx provides a range of market research reports, with the most recent report on augmented, mixed and virtual reality published only a few months ago. “Augmented, Mixed and Virtual Reality 2020-2030: Forecasts, Markets and Technologies” includes market research on AR (augmented reality), VR (virtual reality) and MR (mixed reality) areas, compiled from historic data from nearly 100 companies and over 170 distinct products and forecasts from 2020-2030. It can provide you with the insights into this exciting and growing market area, infiltrating many aspect of users daily lives for many more years to come with its novel use cases and applications.

For more information: www.idtechex.com/

 


Related Content

News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | Ultrasound Imaging

Feb. 25, 2026 — GE HealthCare is introducing the next generation of LOGIQ general imaging ultrasound systems – an ...

Time February 25, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 19, 2026 — GE HealthCare recently announced 510(k) clearance of three new magnetic resonance (MR) innovations with ...

Time February 20, 2026
arrow
News | Radiology Imaging

Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...

Time February 13, 2026
arrow
News | Digital Pathology

Feb. 11, 2026 — Leica Biosystems has announced the global launch of the Leica CM1950 Cryostat with DualEcoTec Cooling ...

Time February 11, 2026
arrow
Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
Subscribe Now